IBPB 001PH

Drug Profile

IBPB 001PH

Alternative Names: IBPB001PH; IBPB001PH (biosimilar) - Inbiopro Solutions

Latest Information Update: 19 Aug 2013

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Inbiopro Solutions
  • Class Antirheumatics; Biological peptides; Osteoporosis therapies; Proteins
  • Mechanism of Action Osteoprotegerin inhibitors; RANK ligand modulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • No development reported Arthritis; Postmenopausal osteoporosis

Most Recent Events

  • 19 Aug 2013 No development reported - Clinical-Phase-Unknown for Arthritis in India (unspecified route)
  • 19 Aug 2013 No development reported - Clinical-Phase-Unknown for Postmenopausal osteoporosis in India (unspecified route)
  • 30 Jun 2010 Clinical trials in Arthritis in India (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top